VEGFA and neoplasm: Somatostatin analogs also display indirect antiproliferative effects through the inhibition of circulating growth factors such as vascular endothelial growth factor, insulin-like growth factor 1 and 2, as well as through the inhibition of tumor angiogenesis [16].